Author: Sadikot, Ruxana T.; Kolanjiyil, Arun V.; Kleinstreuer, Clement; Rubinstein, Israel
Title: Nanomedicine for Treatment of Acute Lung Injury and Acute Respiratory Distress Syndrome Document date: 2017_6_27
ID: 27gutwjd_26
Snippet: Microvascular leakiness in ALI and ARDS is the result of increased permeability, and the presence of inflammatory vasoactive factors that enhance permeability [21] . Thus, drugs used for treatment of ALI and ARDS can be administered systemically and will localize to the lungs by passive targeting. This innovative passively targeted therapeutic strategy amplifies drug delivery to the lung, thereby maximizing efficacy and enhancing resolution of in.....
Document: Microvascular leakiness in ALI and ARDS is the result of increased permeability, and the presence of inflammatory vasoactive factors that enhance permeability [21] . Thus, drugs used for treatment of ALI and ARDS can be administered systemically and will localize to the lungs by passive targeting. This innovative passively targeted therapeutic strategy amplifies drug delivery to the lung, thereby maximizing efficacy and enhancing resolution of inflammation while reducing collateral damage to innocent bystander organs as occurs in patients with ALI and ARDS [8] .
Search related documents:
Co phrase search for related documents- collateral damage and inflammation resolution: 1
- collateral damage and innocent bystander: 1
- collateral damage and lung drug delivery: 1
- drug delivery and increase permeability: 1, 2, 3
- drug delivery and inflammation resolution: 1
- drug delivery and innocent bystander: 1
- drug delivery and lung drug delivery: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24
- drug delivery and passive targeting: 1, 2, 3, 4, 5, 6
Co phrase search for related documents, hyperlinks ordered by date